Smoothened agonist sterosome immobilized hybrid scaffold for bone regeneration.
Chung-Sung LeeSoyon KimJiabing FanHee Sook HwangTara L AghalooMin LeePublished in: Science advances (2020)
Biomaterial delivery of bioactive agents and manipulation of stem cell fate are an attractive approach to promote tissue regeneration. Here, smoothened agonist sterosome is developed using small-molecule activators [20S-hydroxycholesterol (OHC) and purmorphamine (PUR)] of the smoothened protein in the hedgehog pathway as carrier and cargo. Sterosome presents inherent osteoinductive property even without drug loading. Sterosome is covalently immobilized onto three-dimensional scaffolds via a bioinspired polydopamine intermediate to fabricate a hybrid scaffold for bone regeneration. Sterosome-immobilized hybrid scaffold not only provides a favorable substrate for cell adhesion and proliferation but also delivers bioactive agents in a sustained and spatially targeted manner. Furthermore, this scaffold significantly improves osteogenic differentiation of bone marrow stem cells through OHC/PUR-mediated synergistic activation of the hedgehog pathway and also enhances bone repair in a mouse calvarial defect model. This system serves as a versatile biomaterial platform for many applications, including therapeutic delivery and endogenous regenerative medicine.
Keyphrases
- bone regeneration
- tissue engineering
- stem cells
- small molecule
- bone marrow
- cell adhesion
- cell fate
- ionic liquid
- magnetic nanoparticles
- protein protein
- mesenchymal stem cells
- cancer therapy
- signaling pathway
- high throughput
- amino acid
- emergency department
- single cell
- binding protein
- drug delivery
- adverse drug
- bone loss
- soft tissue